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Abstract
Asweknowthatglutamicacidandglutaminearemetabolicallymostreactiveaminoacids,theirpossibleroleinthebiosynthesisofDNAandRNA
and their structural relevance with thalidomide, cycloheximide and tenuazonic acid, investigations on glutamic acid and glutamine analogs as
possible antineoplasticagentswere started in our laboratory in the earlyseventies. In continuation of the above lineofwork, some derivatives
(urides,hydrazidesandhydroxamide)of3,4-Dimethoxybenzenesulphonylglutamicacidwereprepared,characterizedandbiologicallyevaluated
against Ehrlich Ascites Carcinoma (EAC) cells in Swiss Albino mice in terms of tumor weight and ascitic cell count inhibition as activity
parametersusingMitomycin-Casthestandard.
Glutamicacidanalogs,Ehrlichascitescarcinoma,biologicalscreening Keywords:
Antineoplastic agents those mayact through glutamine and/or
folicacidantagonism.
Pyrocatechol, dimethylsulphate, L-(+)- glutamic acid, thionyl
chloridewereobtainedcommerciallyandusedasreceived.
Pyrocatechol obtained commercially, was methylated with
dimethylsulphate in alkaline medium to obtain veratrole .
Chlorosulphonation of veratrole at 0ºC yielded 3,4-
dimethoxybenzenesulphonyl chloride which was then
condensed with L-(+)- glutamic acid to yield 2-N-(3,4-
dimethoxybenzenesulphonyl)-L-(+)- glutamic acid . This
compoundwas refluxed with thionylchloride to yield 2-N-(3,4-
dimethoxybenzene sulph-onyl)-L-(+)-glutamic acid dichloride
.This acidchloride was reactedwithurea toyield 2-N-(3,4-
dimethoxy benzene sulphonyl)-L-(+)- glutamic acid diureide
and with 2,4-dinitrophenyl hydrazine to yield the
corresponding 2,4-dinitrophenyl hydrazide and with
hydroxylamine hydrochloride to yield the corresponding
hydroxamide . In another case the compound 2-N-(3, 4-
dimethoxy benzene sulphonyl)-L-(+)- glutamic acid was
refluxed with acetyl chloride to obtain 1-(3,4-dimethoxy
benzene sulphonyl)-5-oxo -pyrrolidine-2-carboxylic acid .
Thismonoacidwastreatedwiththionylchloridetoyield1-(3,4-
dimethoxy benzene sulphonyl)-5-oxo-pyrrolidine-2-carboxylic
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Introduction
Cancer is the source of modern civilization. Cancer has been
described as nitrogen trap. Glutamine is a non essential but
important amino acid, plays a key role in tumor cell growth by
supplying its amide nitrogen atoms in the biosynthesis of other
amino acids, purine, pyrimidine bases, amino sugars and
coenzymes, via a family comprised of 16amido transferases3,4
with diverse mechanisms. It also plays the principal role in
multiple metabolic pathways and considered to be the most
essential component of tissue culture media for not only as
nitrogensourcebutalsoascarbonsource. Ratesofcellgrowth,
DNA and protein synthesis and thymidine transport correlated
with the glutamine concentration in the culture media.
Glutamine is aprincipalfuel
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utilized byrapidlygrowingtumors.
Numerous studies on glutamine metabolism in cancer indicate
that many tumors are avid consumers of glutamine in-vivo and
in-vitro. Asaconsequenceofprogressivetumorgrowth,host
glutamine depletion develops and becomes a hall mark. This
glutamine depletion occurs in part, because the tumor behaves
as a 'glutamine trap' but also because of cytokine- mediated
alterationsinglutaminemetabolisminhosttissues.Itisfoundin
much higher concentration in tumor cells when compared with
that of normal body cells. Hence, structural variants of glutamic
acid and glutamine were synthesized to develop as possibl
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Characterizationofthecompound
Themelting pointofthe compounds wasreported using open
capillary tube and was uncorrected. Structures of the
compounds were confirmed by neutralization equivalent,
nitrogen estimation by Kjeldhal's method, combustion
analysis, FTIR and 1HNMR spectroscopy. The combustion
analyses indicated by atomic symbols are within ± 0.4% of
acid chloride . This acid chloride thus obtained was reacted
with urea to yield 1-(3, 4-dimethoxy benzene sulphonyl)-5-oxo-
pyrrolidine-2 carboxylic acid ureide and with 2,4-
dinitrophenyl hydrazine to yield the corresponding and with 2,4-
dinitrophenyl hydrazine to yield the corresponding 2,4-dinitro
phenylhydrazide .Theoutlineofthesynthesisisdescribedin
thefollowingscheme:
(8)
(12)
(13)
Devbhuti Synthesis and Biological Screening of Glutamic Acid et al.intermediates and final compounds are summarized in Table 1
and2,respectively.
Antitumor activity of the final compounds was evaluated by
dissolving them in sterile phosphate buffer (pH7.2) and a dose
of 0.02 m mol/kg/day were injected intraperitoneally for seven
consecutive days after intraperitoneal injection of 2x EAC
cells in Swiss albino mice and the activity was estimated in
terms of tumor weight and ascitic cell count inhibition as
activity parameters using Mitomycin C (1mg/kg) as the
standard. The biological activity results are presented in Table
3.
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and there is very little synthetic complication in their
preparation.
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thecalculatedvalues.Theneutralizationequivalentswerewithin
±0.4%ofthecalculatedvalues.FTIRand1HNMRspectroscopy
weredonebyusingJASCOMODELFTIR410spectrophotometer
and the BRUKER MODEL 300 MHz DPX NMR spectrometer
respectively at Indian Institute of Chemical Biology, Jadavpur,
Kolkata. The IR spectra were recorded using KBr pellets. The
1HNMR were done using either DMSO d or CDCl solvent.
3,4-dimethoxy benzene sulphonyl glutamic acid derivatives
were synthesized in accordance with the scheme explained
under the experimental section. Physical data of the
6 3
ResultsandDiscussion
Conclusion
Among the synthesized compounds some showed encouraging
activitywhileothersshowedmoderatetolowactivity.Standard
drug Mitomycin-C at a dose level of 1mg/kg body weight has
shown 100% tumor inhibition. All these compounds have been
synthesized through a very simple and straight forward route
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Compound No. Melting point (ºC) % Yield Molecular formula Molecular weight
2
3
5
6
7
8
-
66-68
143-145
-
128-130
-
83.25
92.62
41.29
-
80.33
-
C H O
C H O SCl
C H O SN
C H O SNCl
C H O SN
C H O SNCl
8 10 2
8 9 4
13 17 8
13 15 6 2
13 15 7
13 14 6
138.0
236.5
347.0
384.0
329.0
347.5
Table 1: Physical data for intermediate compounds
Compound No. Melting point (ºC) % Yield Molecular formula Molecular weight
9
10
11
12
13
202-203
154-155
136-137
195-196
141-142
61.39
65.02
77.63
70.92
69.80
C H O
C H O SCl
C H O SN
C H O SNCl
C H O SN
8 10 2
8 9 4
13 17 8
13 15 6 2
13 15 7
431.0
707.0
377.0
371.0
509.0
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Table 3: Biological activity of the synthesized compounds against EAC cells in mice
9
10
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13
Mito C
247.50 ± 2.78
247.50 ± 2.78
247.50 ± 2.78
247.50 ± 2.78
247.50 ± 2.78
247.50 ± 2.78
3.44 ± 0.21
3.44 ± 0.21
3.44 ± 0.21
3.44 ± 0.21
3.44 ± 0.21
3.44 ± 0.21
1.64* ± 0.78
0.64* ± 0.24
1.06 ± 0.38
2.10* ± 0.85
0.88* ± 0.31
0.00
212.50*±2.02
140.00* ±1.35
67.50 ± 0.94
200.0* ± 1.97
93.75*± 1.26
0.00
14.14
43.43
72.73
19.19
62.12
100
52.32
81.39
69.18
38.95
74.42
100
INB (inhibition), Mean ± SEM, (n=5), * p<0.05: Statistically significant when compared with EAC control group
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Comp No.
No. of ascitic
cells/ ml in
control gr. 'C'
(x cells/ ml) 10
6
No. of ascitic
cells/ml in
test gr. 'T'
(x cells/ml) 10
6
% INB of ascitic
cells (1-T/C)
x100
Weight of ascitic
fluid in control
gr. 'C' (g)
Weight of ascitic
fluid in test
gr. 'T’ (g)
% INB of
ascitic
fluid